EssilorLuxottica completed the acquisition of RetinAI.

EssilorLuxottica, an eyewear desginer and manufacturer, completed the acquisition of RetinAI, a health-technology company focused on AI and data management in eyecare. Financial terms were not disclosed. “In the past year alone, we’ve made several bold moves in med-tech, all with the goal of building the most comprehensive, digitally enabled patient journey. RetinAI will add incredible value to an ecosystem that already includes comprehensive eyecare, advanced diagnostics, therapeutic innovation and surgical excellence. Leveraging its AI-powered analytics, we can turn clinical data into insights that enable faster, more accurate diagnoses and more effective disease monitoring. We are ushering in a new era of healthcare, and it will be transformative for patients everywhere," Francesco Milleri, EssilorLuxottica Chairman and CEO.